Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention

@article{Bandelow2007PregabalinFT,
  title={Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention},
  author={B. Bandelow and D. Wedekind and T. Leon},
  journal={Expert Review of Neurotherapeutics},
  year={2007},
  volume={7},
  pages={769 - 781}
}
  • B. Bandelow, D. Wedekind, T. Leon
  • Published 2007
  • Medicine
  • Expert Review of Neurotherapeutics
  • Pregabalin is the first anxiolytic pharmacologic alternative for the treatment of generalized anxiety disorder (GAD) to be introduced in more than 10 years. GAD is a significant psychiatric condition with lifetime prevalence rates ranging between 5.7 and 6.4%. It causes significant impairment in quality of life and functional abilities equivalent to those associated with major depression. Randomized, controlled trials confirm that pregabalin is superior to placebo and comparable with lorazepam… CONTINUE READING
    Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder
    • 57
    Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature
    • 22
    • Highly Influenced
    Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence
    • 33
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 73 REFERENCES